BPC-157 stands for "Body Protection Compound-157." It's a pentadecapeptide — a chain of 15 amino acids — that represents a stable synthetic sequence derived from a larger protective protein found in human gastric juice. In the world of research peptides, it stands out for the sheer breadth of preclinical work examining it, which is why it anchors our healing and recovery guide.
How it works
The mechanism most associated with BPC-157 in research is angiogenesis — the formation of new blood vessels. Fresh blood vessels carry oxygen and nutrients into an area that's rebuilding, so a compound studied for promoting them is naturally of interest in tissue-repair research. Beyond that, BPC-157 is examined for its interactions with growth-factor signaling and the nitric-oxide system, both of which play roles in how tissue responds to stress and damage. The through-line is localized repair: research tends to focus on what happens at a specific site rather than body-wide effects.
Why gastric stability matters
One reason BPC-157 draws so much research attention is a practical quirk: it derives from a gastric-juice protein and is notably stable in the acidic environment of the stomach, where many peptides would be quickly broken down. That stability is unusual and is part of what made it an interesting research subject in the first place, since most peptides are fragile outside a narrow set of conditions (one reason peptides are generally handled as injectables — see our injection guide).
BPC-157 vs TB-500
These two are the classic research pairing, and the reason is that they work through different mechanisms. BPC-157 is studied more for localized tissue repair and blood-vessel formation; TB-500 is studied more for cell migration and systemic repair signaling. Because the mechanisms complement rather than duplicate each other, researchers frequently examine them together — a comparison we cover in depth in BPC-157 vs TB-500. They also appear together in the Wolverine blend.
Researching BPC-157? It's stocked third-party tested and USA-sourced, with published COAs where available.
View BPC-157Frequently asked questions
What is BPC-157? A synthetic 15-amino-acid peptide (pentadecapeptide) derived from a protective protein in gastric juice, and one of the most-studied research peptides for tissue repair.
How does it work? It's studied for promoting angiogenesis (new blood vessels) and interacting with growth-factor and nitric-oxide pathways involved in localized repair.
How is it different from TB-500? BPC-157 is studied for localized repair and blood-vessel formation; TB-500 for cell migration and systemic signaling. Complementary, which is why they're paired.
Is it approved for human use? No. It's sold strictly for in-vitro research and laboratory use only and is not intended for human consumption.
For in-vitro research and laboratory use only. Not for human consumption. This guide describes research context and mechanisms in general terms; it is not medical advice and makes no claims about outcomes in humans.